MPN-RC 118, the AVID200 trial opened at Mount Sinai in February 2019.

• 2 patients have received treatment and remain on study
• We anticipate that this study will open at participating centers within the next few months.

You can also view more details using the following link:

https://clinicaltrials.gov/ct2/show/NCT03895112?term=NCT03895112&rank=1